Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

RXD vs SBB: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

SBB Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 3–0 Matrix Metrics)

SBB Overall Winner 6-Pillar Tally: RXD 0 – 0 SBB (6 Tie) Matrix Metrics: RXD 0 – 3 SBB

As of Nov 16, 2026, ProShares Short SmallCap600 (SBB) is the stronger overall head-to-head candidate over ProShares UltraShort Health Care (RXD) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). RXD carries a Unified Composite Score of 58.1/100 (HOLD) at $11.95 (N/M Forward P/E, N/A operating margin), whereas SBB carries 74.0/100 (BUY) at $23.65 (N/M Forward P/E, N/A operating margin).

  • Technical & Structure Timing Caution: RXD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.4); meanwhile SBB trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RXD vs SBB
RXD NYSE Arca
ProShares UltraShort Health Care
Institutional Equity
$11.95
+1.01% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -0.21β · 40% Vol
Unified Composite Score
58.1 / 100 HOLD
Tech 80.0 Fund 66.0 Flow 50.0 Mom 68.9
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.9%), weak momentum, RSI 33
RSI-14: 33.4 · SMA20: $12.44 · SMA50: $13.87
SBB NYSE Arca Head-to-Head Winner
ProShares Short SmallCap600
Institutional Equity
$23.65
+1.31% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -0.51β · 21% Vol
Unified Composite Score
74.0 / 100 BUY
Tech 77.0 Fund 58.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (1.8% over 20 days), RSI 54
RSI-14: 53.9 · SMA20: $23.46 · SMA50: $23.60

6-Pillar Scorecard Institutional Category Breakdown (RXD 0 – 0 SBB)

Columns: Metric · RXD · SBB
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 25.2% (<1st %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RXD (0) vs SBB (3)
Institutional Metric RXD SBB Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
29% ($8–$21) 94% ($12–$24) Stronger Trend SBB
Beta / 30D Volatility
Risk Regime
-0.21β · 40% Vol -0.51β · 21% Vol Lower Realized Risk SBB
Unified Institutional Score
Composite Signal
58.1 / 100 (HOLD) 74.0 / 100 (BUY) Higher Composite SBB
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon SBB +9.92 pp
RXD: -11.84% · SBB: -1.92%
3M Horizon SBB +25.95 pp
RXD: -19.72% · SBB: +6.23%
6M Horizon SBB +76.59 pp
RXD: +16.06% · SBB: +92.65%
1Y Horizon SBB +39.9 pp
RXD: +26.9% · SBB: +66.8%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RXD vs SBB. Trailing 12-month operating profitability (RXD N/A vs SBB N/A) and valuation multiples (RXD N/M vs SBB N/M Forward P/E) are benchmarked directly in Pillar 4 below.

RXD ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
SBB ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RXD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 25.2%
IV Percentile <1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RXD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
SBB UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SBB Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RXD Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
SBB Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ RXD vs SBB Key Questions & Quantitative Answers

As of Nov 16, 2026, ProShares Short SmallCap600 (SBB) is the stronger overall head-to-head candidate over ProShares UltraShort Health Care (RXD) in the Tradestie Institutional Equity Comparison Engine, winning 3–0 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). RXD carries a Unified Composite Score of 58.1/100 (HOLD) at $11.95 (N/M Forward P/E, N/A operating margin), whereas SBB carries 74.0/100 (BUY) at $23.65 (N/M Forward P/E, N/A operating margin). Technical & Structure Timing Caution: RXD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.4); meanwhile SBB trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 53.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

RXD and SBB split Growth & Scale metrics: RXD posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with SBB at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, RXD generates N/A in USD-normalized revenue versus N/A for SBB. In operating R&D and SG&A reinvestment, RXD deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for SBB.

RXD and SBB trade at balanced relative valuation multiples. RXD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas SBB trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RXD (N/A ROE) versus SBB (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, RXD carries 25.2% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.21β · 40% Vol realized risk). By comparison, SBB carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.51β · 21% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.